Clinical Trials Directory

Trials / Completed

CompletedNCT00826098

Platelet Rich Plasma (PRP) in Total Knee Replacement

Platelet Rich Plasma (PRP) in Total Knee Replacement: A Prospective, Randomized, Single-blind, Single-center Clinical Study to Evaluate the Effect of Platelet Rich Plasma (PRP) on Short-term Patient Outcomes Following Total Knee Replacement

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Exactech · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Clinical study to evaluate the effect of platelet rich plasma (PRP), a derivative of a patient's whole blood, on short-term patient outcomes following total knee replacement (TKR).

Detailed description

The purpose of this clinical study is to evaluate the effect of platelet rich plasma (PRP), a derivative of a patient's whole blood, on short-term patient outcomes following total knee replacement (TKR). The hypothesis is that change in short-term hemoglobin (Hgb) levels is less dramatic in patients who undergo TKR with the addition of PRP when compared to patients who undergo TKR without PRP.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlatelet Rich PlasmaAddition of PRP to total knee replacement procedure

Timeline

Start date
2008-12-01
Primary completion
2011-06-01
Completion
2013-02-01
First posted
2009-01-21
Last updated
2022-09-01

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00826098. Inclusion in this directory is not an endorsement.

Platelet Rich Plasma (PRP) in Total Knee Replacement (NCT00826098) · Clinical Trials Directory